PRICE T ROWE ASSOCIATES INC /MD/ - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 107 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$200
-44.3%
99,078
+24.0%
0.00%
Q1 2024$359
+106.3%
79,932
+6.6%
0.00%
Q4 2023$174
+56.8%
74,970
-13.9%
0.00%
Q3 2023$111
-71.8%
87,113
-27.0%
0.00%
Q2 2023$394
-21.2%
119,345
-1.7%
0.00%
Q1 2023$500
-29.3%
121,377
+0.7%
0.00%
Q4 2022$707
-99.9%
120,519
+7.6%
0.00%
Q3 2022$758,000
+17.3%
112,039
-19.9%
0.00%
Q2 2022$646,000
+17.2%
139,819
+1.3%
0.00%
Q1 2022$551,000
-22.6%
138,034
+20.6%
0.00%
Q4 2021$712,000
-92.3%
114,447
-88.3%
0.00%
-100.0%
Q3 2021$9,250,000
-70.6%
980,896
-57.7%
0.00%
-66.7%
Q2 2021$31,475,000
-34.6%
2,317,747
-22.1%
0.00%
-40.0%
Q1 2021$48,121,000
-45.3%
2,974,087
-10.0%
0.01%
-44.4%
Q4 2020$87,929,000
+158.2%
3,304,346
+80.7%
0.01%
+125.0%
Q3 2020$34,049,000
+95.3%
1,828,619
+145.4%
0.00%
+100.0%
Q2 2020$17,438,000745,2200.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,663,673$28,503,4842.94%
Logos Global Management LP 2,800,000$9,212,0001.25%
SILVERARC CAPITAL MANAGEMENT, LLC 1,100,000$3,619,0001.12%
5AM Venture Management, LLC 1,305,000$4,293,4501.07%
SILVERARC CAPITAL MANAGEMENT, LLC 1,000,000$3,290,0001.02%
Decheng Capital Management III (Cayman), LLC 904,268$2,975,0420.93%
Sarissa Capital Management LP 2,632,900$8,662,2410.86%
DAFNA Capital Management LLC 810,845$2,667,6800.73%
Tri Locum Partners LP 428,307$1,409,1300.52%
Avidity Partners Management LP 3,790,000$12,469,1000.44%
View complete list of MERSANA THERAPEUTICS INC shareholders